Jinendra Qualipharm Private Limited
About Jinendra Qualipharm Private Limited
Data last updated:
Jinendra Qualipharm Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 October 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2009PTC196480. Its GSTIN is 27AACCJ2407R1Z9 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.3 Lakh. It is led by directors including Ajit Jain and Anju Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹24.3 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹16.89 Cr (net margin 69.5%) and EBITDA of ₹23 Cr (EBITDA margin 94.7%). Revenue has grown at a compounded annual rate (CAGR) of 34% over three years and 219% over five years.
The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹55 Lakh; the latest was in March 2022.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jinendra Qualipharm Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. B – 4001 40th Floor B Wing Lodha Evoq Plot No.Block – C (C1 – Zone) Wadala Truc, K Terminal, Mumbai, Maharashtra, India – 400037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jinendra Qualipharm Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jinendra Qualipharm is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Jinendra Qualipharm Private Limited, buy the company report.
Financials of Jinendra Qualipharm Private Limited
FY 2025 filings availableJinendra Qualipharm Private Limited reported revenue of ₹24.3 Cr (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 219% over five years, including 32% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.89 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 94.7% | ||||
| Net Profit Margin | 69.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jinendra Qualipharm Private Limited, buy the company report.
Board of directors of Jinendra Qualipharm Private Limited
Jinendra Qualipharm has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajit Jain Also directs: Naulakha Impex LLP, Qualigens Pharma Private Limited | Director | 14 Jun 2022 | 4 Years 4 Months | Current |
| Anju Jain Also directs: Aawagaman Mercantile LLP, Vakunth Vinimay LLP, Ajaayu Trading and Consultancy Private Limited and 2 more | Director | 27 Jan 2015 | 11 Years 8 Months | Current |
| Drishti Ajit Jain Also directs: Ajaayu Trading and Consultancy Private Limited | Additional Director | 23 Dec 2024 | 1 Years 10 Months | Current |
| Tina Aayush Jain Also directs: Ajaayu Trading and Consultancy Private Limited | Additional Director | 23 Dec 2024 | 1 Years 10 Months | Current |
| Aayush Jain Also directs: Vakunth Vinimay LLP, Ajaayu Trading and Consultancy Private Limited, Evergrow Marketing Private Limited and 4 more | Director | 27 Jan 2015 | 11 Years 8 Months | Current |
Auditor
Jinendra Qualipharm Private Limited is audited by Desai Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Desai Associates | FY 2023 | 102286W |
Shareholding
The shareholding of Jinendra Qualipharm Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jinendra Qualipharm Private Limited, buy the company report.
Deals & funding
Jinendra Qualipharm Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹55 Lakh; the latest was in March 2022.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Munirabad Trading Limited , Real Stone Exports Limited |
| Feb 2012 | Funding round | ₹40 Lakh | Investors: Real Stone Exports Limited, Munirabad Trading Limited |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Ajaayu Trading and Consultancy Private Limited Seller: Matrix Systel Private Limited |
| Feb 2010 | Funding round | ₹15 Lakh | Investors: Matrix Systel Private Limited |
To see the full deal history of Jinendra Qualipharm Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Jinendra Qualipharm Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jinendra Qualipharm Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jinendra Qualipharm has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCJ2407R1Z9 | Maharashtra | Active | 15 Feb 2021 |
To see the full GST registrations and return filing status of Jinendra Qualipharm Private Limited, buy the company report.
Recent activity
Jinendra Qualipharm Private Limited has 10 board changes on record since 2010: 5 appointments and 5 cessations. The latest: Drishti Ajit Jain was appointed as Additional Director on 23 Dec 2024.
1 earlier event is in the company report.
Frequently asked questions
Jinendra Qualipharm is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 October 2009 (17+ years old) and is registered under CIN U24100MH2009PTC196480.
Jinendra Qualipharm has 5 current directors:
- Ajit Jain - Director
- Anju Jain - Director
- Drishti Ajit Jain - Additional Director
- Tina Aayush Jain - Additional Director
- Aayush Jain - Director
The latest financial statements of Jinendra Qualipharm on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jinendra Qualipharm is 27AACCJ2407R1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Jinendra Qualipharm is U24100MH2009PTC196480. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jinendra Qualipharm was incorporated on 15 October 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
Jinendra Qualipharm has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹55 Lakh; the latest was in March 2022.
Drishti Ajit Jain was appointed as Additional Director on 23 Dec 2024. Tina Aayush Jain was appointed as Additional Director on 23 Dec 2024. Ajit Jain was appointed as Director on 14 Jun 2022. Jinendra Qualipharm has 10 board changes on record in total.
The registered office of Jinendra Qualipharm is at Flat No. B – 4001 40th Floor B Wing Lodha Evoq Plot No.Block – C C1 – Zone Wadala Truc, K Terminal, Mumbai, Maharashtra, India – 400037.
Jinendra Qualipharm operates in the pharma industry, in the drug formulation and development segment.